Use access key #2 to skip to page content.
$12.57 0.31 (2.53%)
9/5/2008 4:00 PM

Boston Scientific Corp. (BSX)

CAPS Rating:
***

The Company develops, manufactures & markets medical devices that are used in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology & neuromodulation.

View All Commentary (BSX)

Recs

3

Avatar tracyrees (98.69) Submitted: 10/09/06 6:43 PM : Outperform Start Price: $14.55 BSX Score: -5.84

Demographics are on their side. Aging boomers will drive revenue for many years to come. Guidant acquisition gives them great supplier pricing power. Revenue and margins will improve.

Report this Post Replies: 0 | Reply

Featured Broker Partners